149 related articles for article (PubMed ID: 35394594)
1. Duodenal Follicular Lymphoma: Track or Treat?
Varanese M; Lauro A; Lattina I; Tripodi D; Daralioti T; Khouzam S; Marino IR; Stigliano V; D'Andrea V; Frattaroli S; Sorrenti S
Dig Dis Sci; 2022 May; 67(5):1733-1738. PubMed ID: 35394594
[TBL] [Abstract][Full Text] [Related]
2. Magnifying Endoscopic Observation of Duodenal Involvement of Follicular Lymphoma before and after Chemotherapy.
Iwamuro M; Okada H; Takata K; Fujii N; Kawano S; Kawahara Y; Yoshino T; Yamamoto K
Intern Med; 2015; 54(14):1741-5. PubMed ID: 26179528
[TBL] [Abstract][Full Text] [Related]
3. [Follicular (nodular) non Hodgkin's lymphoma of tonsil--case report].
Osuch-Wójcikiewicz E; Rzepakowska A; Bruzgielewicz A; Wieczorek J
Otolaryngol Pol; 2007; 61(2):203-6. PubMed ID: 17668812
[TBL] [Abstract][Full Text] [Related]
4. A brief rituximab, bendamustine, mitoxantrone (R-BM) induction followed by rituximab consolidation in elderly patients with advanced follicular lymphoma: a phase II study by the Fondazione Italiana Linfomi (FIL).
Boccomini C; Ladetto M; Rigacci L; Puccini B; Rattotti S; Volpetti S; Ferrero S; Chiarenza A; Freilone R; Novo M; Corradini P; Nassi L; Rusconi C; Stelitano C; Bolis S; Marina Liberati A; Tucci A; Baldini L; Balzarotti M; Evangelista A; Ciccone G; Vitolo U
Br J Haematol; 2021 Apr; 193(2):280-289. PubMed ID: 33476434
[TBL] [Abstract][Full Text] [Related]
5. Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation.
Papaioannou D; Rafia R; Rathbone J; Stevenson M; Buckley Woods H; Stevens J
Health Technol Assess; 2012; 16(37):1-253, iii-iv. PubMed ID: 23021127
[TBL] [Abstract][Full Text] [Related]
6. Ovarian Follicular Lymphoma Diagnosed Due to Hydronephrosis.
Noguchi S; Kimura Y; Shibano S; Ariake C; Iwasawa T; Oyama N; Sato H; Enomoto K; Takahashi N
Intern Med; 2023 Jan; 62(2):293-298. PubMed ID: 35732447
[TBL] [Abstract][Full Text] [Related]
7. Front-line management of non-Hodgkin lymphoma in Australia. Part 1: follicular lymphoma.
Trotman J; Cheah CY; Marlton P; Opat S
Intern Med J; 2019 Apr; 49(4):422-433. PubMed ID: 30230156
[TBL] [Abstract][Full Text] [Related]
8. Primary duodenal follicular lymphoma: 6-years complete remission after combined radio-immunotherapy.
Franco P; Filippi AR; Ciammella P; Botticella A; Namysl-Kaletka A; De Crescenzo A; Tarella C; Ricardi U
Acta Gastroenterol Belg; 2011 Jun; 74(2):337-42. PubMed ID: 21861321
[TBL] [Abstract][Full Text] [Related]
9. Bendamustine plus Rituximab Versus R-CHOP as First-Line Treatment for Patients with Follicular Lymphoma Grade 3A: Evidence from a Multicenter, Retrospective Study.
Mondello P; Steiner N; Willenbacher W; Cerchione C; Nappi D; Mauro E; Ferrero S; Cuzzocrea S; Mian M
Oncologist; 2018 Apr; 23(4):454-460. PubMed ID: 29317554
[TBL] [Abstract][Full Text] [Related]
10. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
11. [Pathological features of duodenal-type follicular lymphoma].
Zhang F; Luo DL; Chen Y; He J; Yan JH; Luo LQ; Luo XL; Liu YH
Zhonghua Bing Li Xue Za Zhi; 2019 Jan; 48(1):22-25. PubMed ID: 30641641
[No Abstract] [Full Text] [Related]
12. [Clinical analysis of eight patients with primary follicular lymphoma in the duodenum].
Tsujioka T; Wada H; Yata K; Kondo T; Suemori S; Tokunaga H; Ohmori K; Kubo Y; Nakanishi H; Mikami M; Haruma K; Sadahira Y; Sugihara T
Rinsho Ketsueki; 2007 Feb; 48(2):134-9. PubMed ID: 17370641
[TBL] [Abstract][Full Text] [Related]
13. Outcomes after R-CHOP in patients with newly diagnosed advanced follicular lymphoma: a 10-year follow-up analysis of the JCOG0203 trial.
Watanabe T; Tobinai K; Wakabayashi M; Morishima Y; Kobayashi H; Kinoshita T; Suzuki T; Yamaguchi M; Ando K; Ogura M; Taniwaki M; Uike N; Yoshino T; Nawano S; Terauchi T; Hotta T; Nagai H; Tsukasaki K;
Lancet Haematol; 2018 Nov; 5(11):e520-e531. PubMed ID: 30389034
[TBL] [Abstract][Full Text] [Related]
14. The role of "watch and wait" in intestinal follicular lymphoma in rituximab era.
Tari A; Asaoku H; Takata K; Fujimori S; Tanaka S; Fujihara M; Koga T; Yoshino T
Scand J Gastroenterol; 2016 Mar; 51(3):321-8. PubMed ID: 26382560
[TBL] [Abstract][Full Text] [Related]
15. Primary follicular lymphoma of the duodenum: a case report and review of literatures.
Charoenlap C; Akarapatima K; Suwanno K; Rattanasupar A; Chang A
Gastroenterol Hepatol Bed Bench; 2021; 14(2):185-189. PubMed ID: 33968348
[TBL] [Abstract][Full Text] [Related]
16. Rituximab in the therapy of stage III and IV follicular lymphoma: Results of the REFLECT 1 study of the Serbian Lymphoma Group.
Popovic S; Jovanovic D; Mihaljevic B; Andjelkovic N; Marjanovic G; Marisavljevic D; Vlaisavljevic N; Popovic L; Salma S; Agic D; Milosevic R; Smiljanic M; Sretenović S; Djurdjević P; Markovic O; Hajder J; Govedarovic N
J BUON; 2017; 22(2):487-494. PubMed ID: 28534374
[TBL] [Abstract][Full Text] [Related]
17. Rituximab: a review of its use in chronic lymphocytic leukaemia, low-grade or follicular lymphoma and diffuse large B-cell lymphoma.
Keating GM
Drugs; 2010 Jul; 70(11):1445-76. PubMed ID: 20614951
[TBL] [Abstract][Full Text] [Related]
18. Outcomes following watchful waiting for stage II-IV follicular lymphoma patients in the modern era.
Nastoupil LJ; Sinha R; Byrtek M; Ziemiecki R; Zhou X; Taylor M; Friedberg JW; Link BK; Cerhan JR; Dawson K; Flowers CR
Br J Haematol; 2016 Mar; 172(5):724-34. PubMed ID: 26729445
[TBL] [Abstract][Full Text] [Related]
19. Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-up.
Czuczman MS; Weaver R; Alkuzweny B; Berlfein J; Grillo-López AJ
J Clin Oncol; 2004 Dec; 22(23):4711-6. PubMed ID: 15483015
[TBL] [Abstract][Full Text] [Related]
20. Management of Adverse Events From the Combination of Rituximab and Lenalidomide in the Treatment of Patients With Follicular and Low-Grade Non-Hodgkin Lymphoma.
Cheson BD; Morschhauser F; Martin P
Clin Lymphoma Myeloma Leuk; 2020 Sep; 20(9):563-571. PubMed ID: 32303486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
